Recent Announcements

Currently Enrolling Studies

C. diff - Clostridium difficile
Men & women age 50 or older. Preventative vaccine. Minimal office visits.

Yeast Infection
Women age 18-65 years with an Active vaginal yeast infection

Women 18-65 with vaginal pain / vulvodynia.

Uterine Fibroids

Pre-menopausal women, 18-50 years of age.
Postmenopausal women, 40-70 years of age, suffering with vaginal dryness, pain, or discomfort, etc.

For more information visit our Research Studies or Contact Us

Yeast Infection? Call Us Before You Treat!!

posted Aug 5, 2015, 10:06 AM by Jennifer Aranda

Contact Us

New Vaginal Cream Study for Menopaual Women !!

posted May 28, 2014, 7:40 AM by Jennifer Aranda

Tackling a Nasty Superbug - Sarasota Herald Tribune

posted Dec 16, 2013, 6:11 AM by Jennifer Aranda

Tackling a nasty superbug

Sarasota Herald-Tribune

December 13, 2013

Barbara Peters Smith


Hospital and nursing home stays are jarring enough for older adults, but anyone who has acquired a case of that nasty superbug, Clostridium difficile — C. diff — will tell you that things can get a lot worse.

 The infection causes diarrhea, leading to about 14,000 deaths a year, according to the Centers for Disease Control. Most at risk are older Americans who have taken antibiotics and experienced prolonged hospital stays. And those are exactly the people wanted for a clinical trial of a new vaccine, involving 15,000 subjects in Sarasota and around the world.

 Some 500,000 of us already carry C. diff bacteria spores around inside us, says Sarasota surgeon Michael Swor, and under certain circumstances, "the spores release the toxin and you get the disease."

 The best defenses, he says, are handwashing and conservative antibiotic use. But with this dire infection so rampant, he's excited about the drug being developed by Sanofi Pasteur. This vaccine, according to its maker, is designed to create an immune response that targets those toxins.

 "This could be a huge benefit for public health for the future, as far as dramatically reducing what has become an unfortunately common acquired infection," Swor says. "Most of us in the scientific world are not worried about whether it works."

 After preliminary human trials for safety, the Food and Drug Administration is fast-tracking the Phase III study. Two of three eligible volunteers will be given the new vaccine, while a third will get a placebo.

 Physician Care Clinical Research in Sarasota is among the first of 100 U.S. sites to begin enrolling subjects, with Swor as the lead investigator.

 If you are 50 or older and are either planning a hospital stay in the next 60 days, or you have had two hospital stays of at least three days in the past year and have taken antibiotics, you could be a candidate for the study. Those who have had C. diff in the past are not eligible. For more information, visit or call 954-2355.

NEW C. diff Vaccine Trial

posted Aug 6, 2013, 8:09 AM by Jennifer Aranda

Physician Care Clinical Research is now testing a NEW vaccine which directs the immune system to produce antibodies against C.diff toxins.

The objective of the Cdiffense trial is to evaluate the safety, immunogenicity and efficacy of a toxoid vaccine for the prevention of primary symptomatic Clostridium difficile Infection ( CDI).

C. diff is emerging as a leading cause of life threatening, health-care acquired infections worldwide. Unfortunately, at this time there are no licensed vaccines available that can prevent C. difficile infection.

Contact Us for more information

Are you suffering with Vaginal Dryness and Pain?

posted Jan 28, 2013, 10:03 AM by Jennifer Aranda

Physician Care Clinical Research is looking for postmenopausal women who experience vaginal dryness or pain to participate in a Vaginal Atrophy study.

Qualified participants must be:
        • between 30 & 75 years of age
        • suffering from vaginal dryness, bleeding or pain due to menopause
        • willing to use a generic, already marketed, or placebo vaginal tablet
        • able to return to our site for multiple visits 

Qualified participants may receive a mammogram or ultrasound as part of the study, as well as compensation for time and travel.

Contact us for more information.

Guess who's on the cover...

posted Jan 10, 2013, 2:09 PM by Jennifer Aranda   [ updated Jan 10, 2013, 2:15 PM ]

Sarasota Magazine Chose Dr. Swor!

Gray Swor, M.D.

Radiation Oncologist

21st Century Oncology

1-6 of 6